Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-05

Clinical Trial Update: Study of Aripiprazole (Abilify) in Children With Symptoms of Mania [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating aripiprazole (Abilify) for children with manic symptoms in bipolar disorder; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abilify (aripiprazole)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-12-05